Corcept Therapeutics Inc
F:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
Olin Corp
NYSE:OLN
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
C
|
Commerzbank AG
XBER:CBK
|
DE |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
P
|
PTC Therapeutics Inc
XMUN:BH3
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 77.08 EUR with a low forecast of 43.37 EUR and a high forecast of 121.72 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
77.08
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 77.08 EUR with a low forecast of 43.37 EUR and a high forecast of 121.72 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
148%
The compound annual growth rate for Operating Income over the next 3 years is 148%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
68%
The compound annual growth rate for Net Income over the next 3 years is 68%.
